10月13日港股通创新药ETF南方（159297）份额增加7100.00万份，最新份额6.64亿份，最新规模6.18亿元

Group 1 - The Hong Kong Stock Connect Innovative Drug ETF (Southern, 159297) experienced a decline of 2.41% on October 13, with a trading volume of 118 million yuan [1] - The fund's shares increased by 71 million, bringing the total shares to 664 million [1] - The latest net asset value of the fund is calculated to be 618 million yuan [1] Group 2 - The performance benchmark for the Hong Kong Stock Connect Innovative Drug ETF is the National Index for Hong Kong Stock Connect Innovative Drugs, adjusted for valuation exchange rates [1] - The fund is managed by Southern Fund Management Co., Ltd., with fund managers Zhang Qisi and Ye Zhenan [1] - Since its establishment on September 12, 2025, the fund has reported a return of -7.04% [1]